Novo Nordisk's Ozempic will become the first and only GLP-1 drug to be shown to reduce progression of kidney disease in ...

Novo Nordisk announced on Thursday that a key European Medicines Agency committee has backed a label update for weight-loss ...

Identifying the early signs of kidney stone disease is crucial for preventing complications and managing symptoms.

Explore the disproportionate burden of chronic kidney disease in the Black community and the need for empowerment and ...

A university has refunded a PhD student's tuition fees due to the distress caused by her being unable to pay for her studies.

New Method Predicts Worsening of Chronic Kidney Disease Sep. 12, 2024 — Researchers have developed a new method that could be a significant step in the treatment of chronic kidney disease.

significantly reduces the risk of progression in chronic kidney disease and cardiovascular mortality in patients with type 2 diabetes. The label expansion could enhance Novo Nordisk’s market ...

Our bodies have several vital organs that quietly toil away to keep us functioning properly. Among these are the kidneys, two fist-sized organs that sit on either side of the spine below the ribs.

The EMA approved a kidney disease–related label expansion for the blockbuster GLP-1 drug after a study showed reduced risk of ...